Eosinophilic fasciitis occurring under treatment with natalizumab for multiple sclerosis

Journal of Cutaneous Medicine and Surgery

Volumn 18, Issue 1, 2014, Pages 69-71

  Bujold, Janie ^a   Boivin, Catherine ^a   Amin, Mohamed ^a   Bouchard, Jean Pierre ^a   Soucy, Jacques ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HYDROXYCHLOROQUINE; NATALIZUMAB;

ADULT; ARTICLE; CASE REPORT; CELLULITIS; DRUG WITHDRAWAL; EOSINOPHILIC FASCIITIS; ERYTHEMA; HUMAN; HUMAN TISSUE; HYPEREOSINOPHILIA; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN INDURATION;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; EOSINOPHILIA; FASCIITIS; HUMANS; HYDROXYCHLOROQUINE; MALE; MULTIPLE SCLEROSIS;

EID: 84892568849     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2013.13026     Document Type: Article

References (10)

1. Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 1975;88: 70-86.
2. Abbas M, Lalive PH, Chofflon M, et al. Hypereosinophilia in patients with multiple sclerosis treated with natalizumab. Neurology 2011;77: 1561-4, doi:10.1212/WNL.0b013e318233b391.
3. Ransohoff RM. Natalizumab for multiple sclerosis. N Engl J Med 2007;356: 2622-9, doi:10.1056/NEJMct071462. (Pubitemid 46961007)
4. Stüve O, Gold R, Chan A, et al. alpha4-Integrin antagonism with natalizumab: effects and adverse effects. J Neurol 2008;255 Suppl 6: 58-65, doi:10.1007/s00415-008-6011-0.
5. Bischoff L, Derk CT. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature Int J Dermatol 2008;47: 29-35, doi:10.1111/j.1365-4632.2007.03544.x.
6. Lakhanpal S, Ginsburg WW, Michet CJ, et al. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988;17: 221-31, doi:10.1016/0049-0172(88)90008-X.
7. Dourmishev LA, Dourmishev AL. Activity of certain drugs in inducing of inflammatory myopathies with cutaneousmanifestations. Expert Opin Drug Saf 2008;7: 421-33, doi:10.1517/14740338.7.4. 421.
8. Buchanan RR, Gordon DA, Muckle TJ, et al. The eosinophilic fasciitis syndrome after phenytoin (dilantin) therapy. J Rheumatol 1980;7: 733-6. (Pubitemid 11173210)
9. Seaman JM, Goble M, Madsen L, et al. Fasciitis and polyarthritis during antituberculous therapy. Arthritis Rheum 1985;28: 1079-84, doi:10.1002/art. 1780281017. (Pubitemid 16250656)
10. André MC, Pacheco D, Antunes J, et al. Generalized skin drug eruption to natalizumab in a patient with multiple sclerosis. Dermatol Online J 2010;16(6): 14.